Anidulafungin is a semisynthetic echinocandin used as an antifungal drug.
Anidulafungin was originally manufactured and submitted for FDA approval by ...
ERAXIS for Injection is a sterile, lyophilized product for intravenous (IV) infusion
that contains anidulafungin. ERAXIS (anidulafungin) is a semi-synthetic ...
Anidulafungin or Eraxis is an anti-fungal drug manufactured by Pfizer that gained
approval by the Food and Drug Administration (FDA) in February 21, 2006; ...
Package Insert for ERAXIS (anidulafungin) for Injection ... The pharmacokinetics
of anidulafungin following IV administration have been characterized in.
Anidulafungin (Eraxis; Pfizer) is the newest echinocandin antifungal to be
approved by the US Food and Drug Administration for the treatment of
Anidulafungin is a cyclic lipopeptide echinocandin derivative with antifungal
activity. Anidulafungin inhibits 1,3 beta-D-glucan synthase, an enzyme involved
Anidulafungin is a semisynthetic product of echinocandin B, itself a fermentation
product of the mold Aspergillus nidulans. It was developed by Eli Lily, ...
Echinocandins represent the newest class of antifungal agents. Currently, three
echinocandins, anidulafungin, caspofungin and micafungin are licensed for ...
Drug information on Eraxis (anidulafungin), includes drug pictures, side effects,
drug interactions, directions for use, symptoms of overdose, and what to avoid.
Find patient medical information for anidulafungin intravenous on WebMD
including its uses, side effects and safety, interactions, pictures, warnings and